Kevin T. Stroupe, PhD
Articles
May 10th 2018
Characteristics and Medication Use of Veterans in Medicare Advantage Plans
Talar W. Markossian, PhD, MPH Katie J. Suda, PharmD, MS Lauren Abderhalden, MS Zhiping Huo, MS Bridget M. Smith, PhD Kevin T. Stroupe, PhD
Veterans enrolled in Medicare Advantage plans differed from fee-for-service sector enrollees in several demographic, geographic, and clinical characteristics and in patterns of medication use.
February 1st 2010
Michael J. Fischer, MD, MSPH Kevin T. Stroupe, PhD James S. Kaufman, MD Ann M. O'Hare, MD Margaret M. Browning, PhD Zhiping Huo, MS Denise M. Hynes, RN, MPH, PhD
Many older veterans do not receive appropriate nephrology care before beginning dialysis. Dual use of Veterans Affairs and Medicare-covered services was associated with better patterns of care.
January 1st 2010
Increasing Copayments and Adherence to Diabetes, Hypertension, and Hyperlipidemic Medications
Matthew L. Maciejewski, PhD Chris L. Bryson, MD, MS Mark Perkins, PharmD David K. Blough, PhD Francesca E. Cunningham, PhD John C. Fortney, PhD Sarah L. Krein, PhD Kevin T. Stroupe, PhD Nancy D. Sharp, PhD Chuan-Fen Liu, PhD
A copayment increase from $2 to $7 adversely affected veterans' adherence to statins, antihypertensives, and oral hypoglycemic agents.
Latest Updated Articles
Published: November 15th 2024 | Updated: November 19th 2024
FDA Approves Revumenib for R/R Acute Leukemia With a KMT2A Translocation
Published: April 1st 2024 | Updated: November 5th 2024
What We're Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Elderly Care Program; Health Care Not Among Top Voter Issues
Published: October 21st 2024 | Updated: October 24th 2024
Lower Diagnostic Error Rates Found Among Hospitalized Patients During Care Transitions
Published: September 26th 2024 | Updated: October 1st 2024
Addressing Natural Disaster Takes Cooperation, Preparation to Ensure Patient Health
Published: May 9th 2024 | Updated: May 21st 2024
FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors
Published: December 17th 2024 | Updated: December 22nd 2024
ICYMI: Highlights From IMS 2024
